根据最新修订的协议条款,AC Immune SA将获得一笔总额为1000万瑞士法郎的预付款。此外,公司还将收到与项目第一阶段进展相关的里程碑付款。此次财务安排进一步巩固了公司的资金流动性,并为后续研发活动提供了有力支持。
根据最新修订的协议条款,AC Immune SA将获得一笔总额为1000万瑞士法郎的预付款。此外,公司还将收到与项目第一阶段进展相关的里程碑付款。此次财务安排进一步巩固了公司的资金流动性,并为后续研发活动提供了有力支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.